DBVT · DBV Technologies S.A.
$13.50
-0.40 (-2.88%)
At close · Jul 28
Market Cap
$4.00B
Shares
296.06M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Pharis Mohideen | Chief Medical Officer | $820,762 |
| Virginie Boucinha | CFO | $458,450 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Pharis Mohideen | Chief Medical Officer | $1,279,518 |
| Virginie Boucinha | CFO | $234,630 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Pharis Mohideen | Chief Medical Officer | $1,076,807 |
| Virginie Boucinha | CFO | — |